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Iowa Department of Public Health 
Division of Behavioral Health/Bureau of Substance Abuse  
Opioid Update: December 2019 
 
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Department News 
• Iowa News 




IDPH Awards Eight Opioid-Related Grant Projects 
 
Through funding made available by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) State Opioid Response (SOR) grant, IDPH awarded eight opioid-
related grant projects. These include: 
 
• Screening, Brief Intervention and Referral to Treatment (SBIRT) 
o Heartland Family Services  
o Mercy Medical Center: Mercy One  
o University of Iowa: Maternal Opioid Agonist Therapy  
• Corrections Liaison 
o Alcohol and Drug Dependency Services  
o Community and Family Resources  
o UCS Healthcare  
o University of Iowa: Bridge Project North  
o University of Iowa: Bridge Project South  
 





Iowa Poison Control Center Issues Opioids Alert  
 
On November 21, 2019, the Iowa Poison Control Center, in partnership with the Iowa 
Department of Public Health, the Department of Public Safety and the Governor’s Office of Drug 
Control Policy, issued an advisory to healthcare professionals regarding opioids.  
 
The alert states that illicit drugs seized by law enforcement and analyzed by the Iowa Division of 
Criminal Investigation's (DCI) laboratory have been found to contain a variety of opiates and 
stimulants. While many of the samples analyzed were found to contain either heroin or fentanyl 
alone, approximately half of the samples were found to have heroin or fentanyl mixed with one 
or more other potent opioids. In addition, some of the samples also included mixtures that 
included stimulants such as methamphetamine and cocaine.  
 
Along with a mixture of substances, the alert was a reminder that the issue of counterfeit opioid 
tablets is still a concern in Iowa. Earlier this year, tablets made to resemble prescription 
oxycodone were found which contained fentanyl, increasing the risks of overdose death. 
 




IDPH Sponsoring Three Upcoming Trainings: 
 
• IDPH will be hosting a training titled, A Closer Look: Methamphetamine, Opioids and 
Poly-Substance Use on December 3, 2019. The purpose of this event is to provide 
information about methamphetamine, opioid and poly-substance use, and explore their 
unique presentations. Speakers will discuss how these particular substances impact 
individuals compared to other types of substance use.  
 
The training will be held at the Ron Pearson Center in West Des Moines. For information 
on registering, please click on the following link: IDPH 
 
• SAVE THE DATE:  
IDPH will be hosting a four-day Recovery Coaching Academy training on January 10-
11 and January 24-25, 2020. The purpose of this event is to train individuals interested 
in helping others address recovery-related issues, from a peer perspective.  
 
IDPH will be hosting a three-day Ethical Considerations for Recovery Coaches 
training February 7-9, 2020. The purpose of this training is to provide coaches with 
additional support and insight into related areas, such as defining the coaching service 
role and functions, coaching standards, issues of vulnerability, ethical decision-making, 
performance enhancement and legal issues.  
 
The Recovery Coaching Academy and Ethics training will be held in Iowa City (location 
being finalized). A limited number of travel and lodging stipends will be made available 
for participants that meet distance eligibility. For more information, please contact Cara 
Weis at cara.weis@idph.iowa.gov.    
 
National Rx Drug Abuse and Heroin Summit: April 13-16 (Nashville) 
 
The Rx Drug Abuse & Heroin Summit is the largest national collaboration of professionals from 
local, state and federal agencies, business, academia, treatment providers, and allied 
communities impacted by prescription drug abuse and heroin use. It is the event for decision 
makers and allied professionals working to address this public health emergency. 
 
To learn more about the Summit or to register, please click on the following link: Rx Summit 
